Erythromycin 333 MG Delayed Release Oral Tablet [PCE]

Known as: ERYTHROMYCIN ETHYLSUCCINATE 333 mg ORAL TABLET [PCE], PCE 333 MG Delayed Release Oral Tablet 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2016
0119802016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The bioremediation of tetrachloroethene (perchloroethene; PCE) contaminated sites generally requires a supply of some fermentable… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2013
2013
This paper reports on the first user/application-driven multi-technology optical sub-wavelength network for intra/inter Data… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
El cómputo de rutas en Internet se ha vuelto una tarea compleja y costosa. La arquitectura PCE (Path Computation Element… (More)
Is this relevant?
2008
2008
The halogenated compound tetrachloroethene (perchloroethene, PCE) is a persistent contaminant of aquifers, soils and sediments… (More)
Is this relevant?
2007
2007
Reductive dehalogenase (RD) gene transcript levels in Dehalococcoides ethenogenes strain 195 were investigated using reverse… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2002
2002
The kinetics, reaction pathways and product distribution of oxidation of tetrachloroethylene (PCE) by potassium permanganate… (More)
Is this relevant?
1980
1980
Findings are described from 13 eyes in which post-cataract-extraction anterior ischemic optic neuropathy (PCE-AION) developed… (More)
Is this relevant?